Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHOD.
作者信息
Choi Jun Yong, Zhou Jialun, Giles Michelle, Broom Jennifer, Templeton David J, Law Matthew G, Chaiwarith Romanee, Tanuma Junko
出版信息
J Acquir Immune Defic Syndr. 2011 May 1;57(1):e13-5. doi: 10.1097/qai.0b013e31820fffba.
Abstract
摘要
相似文献
1
Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHOD.亚洲和澳大利亚人群中初治的HIV感染患者对抗逆转录病毒联合治疗反应不一致的预测因素及结果：亚太地区HIV初治患者队列研究（APHOD）结果
J Acquir Immune Defic Syndr. 2011 May 1;57(1):e13-5. doi: 10.1097/qai.0b013e31820fffba.
2
Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.接受基于非核苷类逆转录酶抑制剂的高效抗逆转录病毒疗法的人类免疫缺陷病毒感染儿童的免疫恢复模式及预测因素
Pediatr Infect Dis J. 2009 Jun;28(6):488-92. doi: 10.1097/inf.0b013e318194eea6.
3
Immunologic and virologic responses to antiretroviral therapy in treatment-naïve, HIV-infected elderly patients.初治的HIV感染老年患者对抗逆转录病毒治疗的免疫和病毒学反应。
Int J STD AIDS. 2019 Nov;30(13):1304-1310. doi: 10.1177/0956462419872857. Epub 2019 Nov 15.
4
HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).艾滋病毒与衰老：来自亚太地区艾滋病毒观察数据库（APHOD）的见解。
HIV Med. 2015 Mar;16(3):152-60. doi: 10.1111/hiv.12188. Epub 2014 Nov 18.
5
Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.在资源有限国家开始接受治疗的既往未接受过治疗的HIV-1感染成人中，对强效抗逆转录病毒治疗的不一致反应：低收入国家抗逆转录病毒治疗（ART-LINC）合作项目
J Acquir Immune Defic Syndr. 2007 May 1;45(1):52-9. doi: 10.1097/QAI.0b013e318042e1c3.
6
Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的患者血浆HIV-RNA和CD4淋巴细胞计数的变化。
AIDS. 1999 Aug 20;13(12):1594-5. doi: 10.1097/00002030-199908200-00029.
7
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and the Henry J. Kaiser Family Foundation.《HIV感染成人及青少年抗逆转录病毒药物使用指南》。美国卫生与公众服务部及亨利·J·凯泽家庭基金会。
Ann Intern Med. 1998 Jun 15;128(12 Pt 2):1079-100. doi: 10.7326/0003-4819-128-12_part_2-199806151-00003.
8
"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.在一组密切随访的开始抗逆转录病毒治疗的患者中，CD4细胞计数相对于血浆病毒载量出现“不一致”的增加。
J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):159-66. doi: 10.1097/00042560-200206010-00004.
9
Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.根据CD4细胞计数，无症状且未接受过抗逆转录病毒治疗的HIV-1感染受试者对高效抗逆转录病毒治疗的病毒学和免疫学反应。
AIDS. 2000 Oct 20;14(15):2257-63. doi: 10.1097/00002030-200010200-00006.
10
Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study.卢旺达对抗逆转录病毒联合疗法的不一致治疗反应：一项前瞻性队列研究。
PLoS One. 2016 Jul 20;11(7):e0159446. doi: 10.1371/journal.pone.0159446. eCollection 2016.
本文引用的文献
1
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.在欧洲，严重的致命和非致命的非艾滋病定义疾病。
J Acquir Immune Defic Syndr. 2010 Oct;55(2):262-70. doi: 10.1097/QAI.0b013e3181e9be6b.
2
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.资源有限环境下抗逆转录病毒治疗中不相符反应与死亡率的相关性。
J Acquir Immune Defic Syndr. 2010 Jan;53(1):70-7. doi: 10.1097/QAI.0b013e3181c22d19.
3
Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression.尽管病毒得到持续抑制，但基线免疫功能较差预示着对抗逆转录病毒联合治疗的免疫反应不完全。
J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):307-13. doi: 10.1097/QAI.0b013e3181945ed4.
4
Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.对高效抗逆转录病毒疗法呈现免疫和病毒学反应不一致的初治HIV感染患者的临床结局
J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):553-8. doi: 10.1097/QAI.0b013e31816856c5.
5
Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.在资源有限国家开始接受治疗的既往未接受过治疗的HIV-1感染成人中，对强效抗逆转录病毒治疗的不一致反应：低收入国家抗逆转录病毒治疗（ART-LINC）合作项目
J Acquir Immune Defic Syndr. 2007 May 1;45(1):52-9. doi: 10.1097/QAI.0b013e318042e1c3.
6
Discordant immunological and virological responses to antiretroviral therapy.对抗逆转录病毒疗法的免疫和病毒学反应不一致。
J Antimicrob Chemother. 2006 Sep;58(3):506-10. doi: 10.1093/jac/dkl263. Epub 2006 Jul 19.
7
Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.对高效抗逆转录病毒疗法的免疫和病毒学反应不一致与死亡率增加及治疗依从性差有关。
J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):288-93. doi: 10.1097/01.qai.0000182847.38098.d1.
8
The TREAT Asia HIV Observational Database: baseline and retrospective data.亚太地区艾滋病治疗观察数据库：基线数据与回顾性数据
J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9. doi: 10.1097/01.qai.0000145351.96815.d5.
9
Rates of combination antiretroviral treatment change in Australia, 1997-2000.1997 - 2000年澳大利亚联合抗逆转录病毒治疗的比率变化
HIV Med. 2002 Jan;3(1):28-36. doi: 10.1046/j.1464-2662.2001.00094.x.
10
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.根据高效抗逆转录病毒疗法6个月后的免疫和病毒学反应，HIV-1感染患者的临床结局
Ann Intern Med. 2000 Sep 19;133(6):401-10. doi: 10.7326/0003-4819-133-6-200009190-00007.
Zotero 插件